Efg Capital International Corp. Legend Biotech Corp Call Options Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
202Shares Held
74.3MCall Options Held
371KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$470 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$307 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$272 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$234 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$195 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.86B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...